Found: 26
Select item for more details and to access through your institution.
Use of SuperARMS EGFR Mutation Detection Kit to Detect EGFR in Plasma Cell-free DNA of Patients With Lung Adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 209, doi. 10.1007/s10637-021-01163-w
- By:
- Publication type:
- Article
Ambient Air Pollution and Vision Disorder: A Systematic Review and Meta-Analysis.
- Published in:
- Toxics, 2024, v. 12, n. 3, p. 209, doi. 10.3390/toxics12030209
- By:
- Publication type:
- Article
Utility and Safety of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Diagnosis of Isolated Mediastinal Masses.
- Published in:
- Journal of Multidisciplinary Healthcare, 2021, v. 14, p. 2047, doi. 10.2147/JMDH.S317060
- By:
- Publication type:
- Article
miR-135a Regulates Atrial Fibrillation by Targeting Smad3.
- Published in:
- Cardiovascular Therapeutics, 2023, p. 1, doi. 10.1155/2023/8811996
- By:
- Publication type:
- Article
G4-Tetra DNA Duplex Induce Lung Cancer Cell Apoptosis in A549 Cells.
- Published in:
- Nanoscale Research Letters, 2016, v. 11, n. 1, p. 1, doi. 10.1186/s11671-016-1652-x
- By:
- Publication type:
- Article
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer.
- Published in:
- Advanced Science, 2019, v. 6, n. 19, p. N.PAG, doi. 10.1002/advs.201900721
- By:
- Publication type:
- Article
Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3171, doi. 10.1007/s00432-022-04182-z
- By:
- Publication type:
- Article
Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 401, doi. 10.1007/s00432-019-03064-1
- By:
- Publication type:
- Article
EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. e395, doi. 10.1016/j.cllc.2020.06.005
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Is there a progression-free survival benefit of first-line crizotinib versus standard chemotherapy and second-line crizotinib in ALK-positive advanced lung adenocarcinoma? A retrospective study of Chinese patients.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 6, p. 1013, doi. 10.1002/cam4.659
- By:
- Publication type:
- Article
Clinical Experience with First-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients with Brain Metastasis.
- Published in:
- Chinese Journal of Lung Cancer, 2017, v. 20, n. 2, p. 114, doi. 10.3779/j.issn.1009-3419.2017.02.06
- By:
- Publication type:
- Article
Retrospectively Analysis of Factors Influencing the Relapse (or Progression) of Newly Diagnosed Nonoperative Small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2015, v. 18, n. 9, p. 529, doi. 10.3779/j.issn.1009-3419.2015.09.01
- By:
- Publication type:
- Article
The Clinical Analysis of 21 Patients with Lymphoepithelioma-like Carcinoma after Operation.
- Published in:
- Chinese Journal of Lung Cancer, 2009, v. 12, n. 11, p. 1169, doi. 10.3779/j.issn.1009-3419.2009.11.08
- By:
- Publication type:
- Article
Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/8811487
- By:
- Publication type:
- Article
Efficacy and tolerability of crizotinib in the treatment of ALK-positive, advanced non-small cell lung cancer in Chinese patients.
- Published in:
- Medical Oncology, 2015, v. 32, n. 6, p. 1, doi. 10.1007/s12032-015-0626-7
- By:
- Publication type:
- Article
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment.
- Published in:
- Cancer Biology & Medicine, 2018, v. 15, n. 4, p. 443, doi. 10.20892/j.issn.2095-3941.2018.0158
- By:
- Publication type:
- Article
A Re-Examination of Neoadjuvant Therapy for Thymic Tumors: A Long and Winding Road.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1680, doi. 10.3390/cancers16091680
- By:
- Publication type:
- Article
P‐125: Real‐time Rotating Display System Based on Active‐Matrix Micro‐LED Glass Backplane.
- Published in:
- SID Symposium Digest of Technical Papers, 2024, v. 55, n. 1, p. 1874, doi. 10.1002/sdtp.17950
- By:
- Publication type:
- Article
P‐9.20: Real‐time Rotating Display System Based on Active‐Matrix Micro‐LED Glass Backplane.
- Published in:
- SID Symposium Digest of Technical Papers, 2024, v. 55, n. 1, p. 1227, doi. 10.1002/sdtp.17328
- By:
- Publication type:
- Article
P‐9.14: A method of Improving Image Quality of VRR Flicker.
- Published in:
- SID Symposium Digest of Technical Papers, 2024, v. 55, n. 1, p. 1205, doi. 10.1002/sdtp.17322
- By:
- Publication type:
- Article
17‐2: A method of improving image contrast based on Dual Cell display.
- Published in:
- SID Symposium Digest of Technical Papers, 2020, v. 51, n. 1, p. 228, doi. 10.1002/sdtp.13845
- By:
- Publication type:
- Article
Efforts to alter the trajectory of neonatal mortality in Malawi: evaluating relative effects of access to maternal care services and birth history risk factors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer.
- Published in:
- PLoS Genetics, 2016, v. 12, n. 4, p. 1, doi. 10.1371/journal.pgen.1005895
- By:
- Publication type:
- Article
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302).
- Published in:
- 2018
- By:
- Publication type:
- journal article